They could be boosted though by the acquisition in May of the Greek pharmaceutical company Specifar for 400m euros by Watson Pharmaceuticals of California, which has its headquarters in New Jersey.
Ipak, mogle bi biti povećane zbog grčke farmaceutske tvrtke Specifar, koju je u svibnju za 400 milijuna eura kupio Watson Pharmaceuticals iz Kalifornije, sa sjedištem u New Jerseyu.